Tumors with inherited or somatic deficiencies in HRR genes, such as BRCA1, BRCA2, PALB2, and RAD51, exhibit synthetic lethality to PARPis, including olaparib, rucaparib, niraparib, and talazoparib, which have shown durable efficacy in BRCA-mutant breast, ovarian, and prostate cancers
Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated
Topical diclofenac gel applied directly to the painful area reduces localized inflammation without the systemic downsides of oral NSAIDs
Diagnostic features: May be a sessile broad-based mass or characterized by diffusely thickening of mucosa
Recognizing when you are deficient in glutathione and curbing these mistakes is essential for maintaining optimal health and keeping oxidative stress at bay